Jefferies Maintains Hold on Abbott Laboratories, Raises Price Target to $125

Benzinga · 10/17 13:47
Jefferies analyst Matthew Taylor maintains Abbott Laboratories (NYSE:ABT) with a Hold and raises the price target from $120 to $125.